Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HUMA
#3068
Humacyte, Inc. Common Stock
1.1
2
-6.67%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-6.67%
Monthly Change
+7.69%
6 month change
-28.66%
Year Change
-66.06%
Previous Close
1.2
0
Open
1.1
2
Bid
Ask
Low
1.1
2
High
1.1
2
Volume
61
Markets
US Stock Market
Healthcare
HUMA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
Humacyte stock jumps after securing DoD funding for vascular repair tech
DoD allocates funds for bioengineered vascular repair tech in 2026 budget
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider
Benchmark lowers Humacyte stock price target to $10 on Israel filing plans
Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?
Humacyte plans to seek approval for vessel product in Israel
Humacyte secures up to $77.5 million credit facility with Avenue Capital
Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest?
Humacyte stock rating reiterated at Buy by H.C. Wainwright
Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views?